Reported results
- Revenue for the third quarter of 2026 was $4.2 million, compared with $9.6 million for the same period in 2025.
- Research and development expenses were $82.3 million for the third quarter of 2026, compared with $62.2 million for the same period in 2025.
- General and administrative expenses were $13.5 million for the third quarter of 2026, compared with $10.3 million for the same period in 2025.
- Net loss was $87.7 million for the third quarter of 2026, compared with $60.0 million for the same period in 2025.
- Cash, cash equivalents, and marketable securities were $404.2 million as of Sept. 30, 2026.
Price and volatility reaction
The stock moved -6.8% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 13.49 | 2026-11-11 |
| Close after release | 12.57 | 2026-11-12 |
| Realised move | -6.8% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.
